Melanoma progression in a changing environment

European Journal of Cell Biology

Volumn 86, Issue 2, 2007, Pages 65-67

  van Kempen, Léon C L ^a   van Muijen, Goos N P ^a   Ruiter, Dirk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CANCER GROWTH; CANCER INVASION; DERMIS; EDITORIAL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; SKIN CARCINOGENESIS;

EID: 33846464596     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2006.12.001     Document Type: Editorial

References (15)

1. Albelda S.M., Mette S.A., Elder D.E., Stewart R., Damjanovich L., Herlyn M., and Buck C.A. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res. 50 (1990) 6757-6764
2. Clark Jr. W.H., From L., Bernardino E.A., and Mihm M.C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 29 (1969) 705-727
3. De Waal R.M., van Altena M.C., Erhard H., Weidle U.H., Nooijen P.T., and Ruiter D.J. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. Am. J. Pathol. 150 (1997) 1951-1957
4. Elder D.E. Pathology of melanoma. Clin. Cancer Res. 12 (2006) 2308s-2311s
5. Hawkins W.G., Busam K.J., Ben-Porat L., Panageas K.S., Coit D.G., Gyorki D.E., Linehan D.C., and Brady M.S. Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. Ann. Surg. Oncol. 12 (2005) 207-213
6. Hsu M.Y., Meier F., and Herlyn M. Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70 (2002) 522-536
7. Mihm Jr. M.C., Clark Jr. W.H., and From L. The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N. Engl. J. Med. 284 (1971) 1078-1082
8. Pawelek J., Chakraborty A., Lazova R., Yilmaz Y., Cooper D., Brash D., and Handerson T. Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion?. Contrib. Microbiol. 13 (2006) 138-155
9. Ruiter D., Bogenrieder T., Elder D., and Herlyn M. Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol. 3 (2002) 35-43
10. van Kempen L.C., van den Oord J.J., van Muijen G.N., Weidle U.H., Bloemers H.P., and Swart G.W. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am. J. Pathol. 156 (2000) 769-774
11. van Kempen L.C., Ruiter D., van Muijen G.N., and Coussens L.M. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur. J. Cell Biol. 82 (2003) 539-548
12. van Kempen L.C., Rijntjes J., Claes A., Blokx W.A., Gerritsen M.J., Ruiter D.J., and van Muijen G.N. Type I collagen synthesis parallels the conversion of keratinocytic intraepidermal neoplasia to cutaneous squamous cell carcinoma. J. Pathol. 204 (2004) 333-339
13. van Kempen L.C., van Muijen G.N., and Ruiter D.J. Stromal responses in human primary melanoma of the skin. Front. Biosci. 10 (2005) 2922-2931
14. van Kempen L.C., Rijntjes J., Mamor-Cornelissen I., Vincent-Naulleau S., Gerritsen M.J., Ruiter D., van Dijk M.C., Geffrotin C., and van Muijen G.N. Type I collagen turnover is a critical parameter for melanoma progression. Melanoma Res. 16 (2006) S71 (Abstract)
15. Vincent-Naulleau S., Le Chalony C., Leplat J.J., Bouet S., Bailly C., Spatz A., Vielh P., Avril M.F., Tricaud Y., Gruand J., Horak V., Frelat G., and Geffrotin C. Clinical and histopathological characterization of cutaneous melanomas in the melanoblastoma-bearing Libechov minipig model. Pigment Cell Res. 17 (2004) 24-35